Journal of Applied Physiology, Vol 81, Issue 3 1255-1263, Copyright © 1996 by American Physiological Society

ARTICLES

Eicosanoids modulate hyperpnea-induced bronchoconstriction in canine peripheral airways

C. Omori, P. Tagari and A. N. Freed
Department of Environmental Health Sciences, Johns Hopkins University, Baltimore, Maryland 21205, USA.

We examined the role of leukotrienes (LTs) in the development of dry air-induced bronchoconstriction (AIB) in canine peripheral airways. Airway reactivity to exogenous LTs was first tested by using an LTD4 aerosol challenge: peripheral airway resistance increased approximately 130 +/- 51% (n = 4) above baseline when compared with its vehicle control. AIB was then assessed by measuring peripheral airway resistance after, and airway wall temperature during, a dry air challenge (DAC). Treatment with a peptidoleukotriene biosynthesis inhibitor (MK-0591) attenuated AIB by approximately 65% without altering airway wall temperature. The fact that MK-0591 did not alter airway reactivity to aerosolized acetylcholine and completely inhibited Ca2+ ionophore-induced LTB4 generation in canine whole blood attests to the specificity of the drug. Treatment with MK-0591 did not affect the increased number of epithelial cells recovered in bronchoalveolar lavage fluid 5 min after DAC. Concentrations of LTs and other eicosanoids in bronchoalveolar lavage fluid from vehicle-treated DAC airways were increased above baseline values; only LTs were reduced by MK-0591. Before MK-0591, AIB was significantly correlated with the dry air-induced generation of LTC4, LTD4, and LTE4. After treatment with MK-0591, AIB was correlated with thromboxane B2, prostaglandin (PG) F2 alpha, and PGE2. We conclude that hyperpnea with dry air stimulates local production and release of LTs in canine bronchi and, alone with the generation of bronchoconstricting and bronchodilating PGs, plays a central role in the modulation of AIB.

This article has been cited by other articles:

				T. S. Hallstrand, M. W. Moody, M. M. Wurfel, L. B. Schwartz, W. R. Henderson Jr., and M. L. Aitken Inflammatory Basis of Exercise-induced Bronchoconstriction Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 679 - 686. [Abstract] [Full Text] [PDF]

				A. N. Freed, S. McCulloch, T. Meyers, and R. Suzuki Neurokinins Modulate Hyperventilation-induced Bronchoconstriction in Canine Peripheral Airways Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1102 - 1108. [Abstract] [Full Text] [PDF]

				R. SUZUKI and A. N. FREED Heparin Inhibits Hyperventilation-Induced Late-Phase Hyperreactivity in Dogs Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 27 - 33. [Abstract] [Full Text] [PDF]

				R. Suzuki and A. N. Freed Hypertonic saline aerosol increases airway reactivity in the canine lung periphery J Appl Physiol, December 1, 2000; 89(6): 2139 - 2146. [Abstract] [Full Text] [PDF]

				A. N. Freed, S. McCulloch, and Y. Wang Eicosanoid and muscarinic receptor blockade abolishes hyperventilation-induced bronchoconstriction J Appl Physiol, November 1, 2000; 89(5): 1949 - 1955. [Abstract] [Full Text] [PDF]

				R. SUZUKI and A. N. FREED Heparin Inhibits Eicosanoid Metabolism and Hyperventilation-induced Bronchoconstriction in Dogs Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1850 - 1854. [Abstract] [Full Text]

				A. N. Freed, Y. Wang, S. McCulloch, T. Myers, and R. Suzuki Mucosal injury and eicosanoid kinetics during hyperventilation-induced bronchoconstriction J Appl Physiol, November 1, 1999; 87(5): 1724 - 1733. [Abstract] [Full Text] [PDF]

				X. X. Yang, W. S. Powell, L. J. Xu, and J. G. Martin Strain dependence of the airway response to dry-gas hyperpnea challenge in the rat J Appl Physiol, January 1, 1999; 86(1): 152 - 158. [Abstract] [Full Text] [PDF]

				A. N. Freed, V. Taskar, B. Schofield, and C. Omori Hyperventilation-induced airway injury and vascular leakage in dogs: effects of alpha 1-adrenergic agonists J Appl Physiol, December 1, 1997; 83(6): 1884 - 1889. [Abstract] [Full Text] [PDF]